Sigachi Industries Limited's arm signs MoU with Respilon Group s.r.o

Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries Limited, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.

The MoU was signed between Mr. Lijo Chacko, Managing Director of Sigachi MENA FZCO, and Mr. Roman Zima, Chief Business Officer of Respilon Group s.r.o, during a formal ceremony on April 24, 2025.

Strategic Highlights of the MoU:

- Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX® nanofiber technology.

- Focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.

- The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.

Commenting on this development, Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited stated "Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve therapeutic outcomes and elevate the patient experience. We are excited about the possibilities NUENEX® technology offers to revolutionize drug delivery systems globally."

Commenting on this development, Mr. Roman Zima, Chief Business Officer of Respilon Group s.r.o stated "We are delighted to partner with Sigachi, whose deep industry expertise and global reach will accelerate the deployment of NUENEX® across pharmaceutical markets. Together, we aspire to redefine drug delivery with safer, more effective, and sustainable solutions for patients worldwide."

Source : Equity Bulls

Keywords

SigachiIndustries SigachiMENAFZCO MoU Respilon